Cochrane Abstracts
Oral and sublingual immunotherapy for egg allergy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral and Sublingual Immunotherapy for Egg Allergy." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433085/all/Oral_and_sublingual_immunotherapy_for_egg_allergy.
Oral and sublingual immunotherapy for egg allergy. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433085/all/Oral_and_sublingual_immunotherapy_for_egg_allergy. Accessed February 4, 2025.
Oral and sublingual immunotherapy for egg allergy. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433085/all/Oral_and_sublingual_immunotherapy_for_egg_allergy
Oral and Sublingual Immunotherapy for Egg Allergy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433085/all/Oral_and_sublingual_immunotherapy_for_egg_allergy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral and sublingual immunotherapy for egg allergy
ID - 433085
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433085/all/Oral_and_sublingual_immunotherapy_for_egg_allergy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
